Authors:
Multanen, M
Talja, M
Hallanvuo, S
Siitonen, A
Valimaa, T
Tammela, TLJ
Seppala, J
Tormala, P
Citation: M. Multanen et al., Bacterial adherence to silver nitrate coated poly-L-lactic acid urologicalstents in vitro, UROL RES, 28(5), 2000, pp. 327-331
Authors:
Aho, M
Koivisto, AM
Tammela, TLJ
Auvinen, A
Citation: M. Aho et al., Is the incidence of hypospadias increasing? Analysis of Finnish hospital discharge data 1970-1994, ENVIR H PER, 108(5), 2000, pp. 463-465
Authors:
Finne, P
Finne, R
Auvinen, A
Juusela, H
Aro, J
Maattanen, L
Hakama, M
Rannikko, S
Tammela, TLJ
Stenman, UH
Citation: P. Finne et al., Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network, UROLOGY, 56(3), 2000, pp. 418-422
Citation: H. Tainio et al., Ulcer perforation in gastric urinary conduit: Never use a gastric segment in the urinary tract if there are other options available, UROL INTERN, 64(2), 2000, pp. 101-102
Authors:
Petas, A
Isotalo, T
Talja, M
Tammela, TLJ
Valimaa, T
Tormala, P
Citation: A. Petas et al., A randomised study to evaluate the efficacy of a biodegradable stent in the prevention of postoperative urinary retention after interstitial laser coagulation of the prostate, SC J UROL N, 34(4), 2000, pp. 262-266
Authors:
Finne, P
Zhang, WM
Auvinen, A
Leinonen, J
Maattanen, L
Rannikko, S
Tammela, TLJ
Stenman, UH
Citation: P. Finne et al., Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer, J UROL, 164(6), 2000, pp. 1956-1960
Authors:
Palmberg, C
Koivisto, P
Kakkola, L
Tammela, TLJ
Kallioniemi, OP
Visakorpi, T
Citation: C. Palmberg et al., Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer, J UROL, 164(6), 2000, pp. 1992-1995
Authors:
Iversen, P
Tyrrell, CJ
Kaisary, AV
Anderson, JB
Van Poppel, H
Tammela, TLJ
Chamberlain, M
Carroll, K
Melezinek, I
Citation: P. Iversen et al., Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup, J UROL, 164(5), 2000, pp. 1579-1582
Authors:
Koskimaki, J
Hakama, M
Huhtala, H
Tammela, TLJ
Citation: J. Koskimaki et al., Effect of erectile dysfunction on frequency of intercourse: A population based prevalence study in Finland, J UROL, 164(2), 2000, pp. 367-370
Authors:
Raitanen, MP
Marttila, T
Kaasinen, E
Rintala, E
Aine, R
Tammela, TLJ
Citation: Mp. Raitanen et al., Sensitivity of human complement factor H related protein (BTA stat) test and voided urine cytology in the diagnosis of bladder cancer, J UROL, 163(6), 2000, pp. 1689-1692
Authors:
Mononen, N
Syrjakoski, K
Matikainen, M
Tammela, TLJ
Schleutker, J
Kallioniemi, OP
Trapman, J
Koivisto, PA
Citation: N. Mononen et al., Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene, CANCER RES, 60(22), 2000, pp. 6479-6481
Authors:
Matikainen, MP
Schleutker, J
Morsky, P
Kallioniemi, OP
Tammela, TLJ
Citation: Mp. Matikainen et al., Detection of subclinical cancers by prostate-specific antigen screening inasymptomatic men from high-risk prostate cancer families, CLIN CANC R, 5(6), 1999, pp. 1275-1279
Authors:
Isotalo, T
Halasz, A
Talja, M
Tammela, TLJ
Paasimaa, S
Tormala, P
Citation: T. Isotalo et al., Tissue biocompatibility of a new caprolactone-coated self-reinforced self-expandable poly-L-lactic acid bioabsorbable urethral stent, J ENDOUROL, 13(7), 1999, pp. 525-530
Authors:
Tammela, TLJ
Schafer, W
Barrett, DM
Abrams, P
Hedlund, H
Rollema, HJ
Matos-Ferreira, A
Nordling, J
Bruskewitz, R
Miller, P
Kirby, R
Andersen, JT
Jacobsen, C
Gormley, GJ
Malice, MP
Bach, MA
Citation: Tlj. Tammela et al., Repeated pressure-flow studies in the evaluation of bladder outlet obstruction due to benign prostatic enlargement, NEUROUROL U, 18(1), 1999, pp. 17-24
Authors:
Palmberg, C
Koivisto, P
Visakorpi, T
Tammela, TLJ
Citation: C. Palmberg et al., PSA decline is an independent prognostic marker in hormonally treated prostate cancer, EUR UROL, 36(3), 1999, pp. 191-196
Citation: M. Leppilahti et al., Duration of increased mucosal permeability of the urinary bladder after acute overdistension: an experimental study in rats, UROL RES, 27(4), 1999, pp. 272-276
Authors:
Isotalo, T
Talja, M
Tammela, TLJ
Tormala, P
Paasimaa, S
Andersson, L
Citation: T. Isotalo et al., Cytotoxicity testing of a new caprolactone-coated self-expanding bioabsorbable self-reinforced poly-L-lactic acid urethral stent, UROL RES, 27(2), 1999, pp. 149-152
Authors:
Laaksovirta, S
Rajala, P
Nurmi, M
Tammela, TLJ
Laato, M
Citation: S. Laaksovirta et al., The cytostatic effect of 9-cis-retinoic acid, tretinoin, and isotretinoin on three different human bladder cancer cell lines in vitro, UROL RES, 27(1), 1999, pp. 17-22
Authors:
Schafer, W
Tammela, TLJ
Barrett, DM
Abrams, P
Hedlund, H
Rollema, HJ
Nordling, J
Andersen, JT
Hald, T
Matos-Ferriera, A
Bruskewitz, R
Miller, P
Mustonen, S
Cannon, A
Malice, MP
Jacobsen, CA
Bach, MA
Citation: W. Schafer et al., Continued improvement in pressure-flow parameters in men receiving finasteride for 2 years, UROLOGY, 54(2), 1999, pp. 278-283
Citation: Mp. Raitanen et Tlj. Tammela, Specificity of human complement factor H-related protein test (Bard BTA stat test), SC J UROL N, 33(4), 1999, pp. 234-236
Authors:
Isotalo, T
Alarakkola, E
Talja, M
Tammela, TLJ
Valimaa, T
Tormala, P
Citation: T. Isotalo et al., Biocompatibility testing of a new bioabsorbable X-ray positive SR-PLA 96/4urethral stent, J UROL, 162(5), 1999, pp. 1764-1767
Authors:
Abrams, P
Schafer, W
Tammela, TLJ
Barrett, DM
Hedlund, H
Rollema, HJ
Matos-Ferreira, A
Nordling, J
Bruskewitz, R
Andersen, JT
Hald, T
Miller, P
Kirby, R
Mustonen, S
Cannon, A
Jacobsen, CA
Gormley, GJ
Malice, MP
Bach, MA
Citation: P. Abrams et al., Improvement of pressure flow parameters with finasteride is greater in menwith large prostates, J UROL, 161(5), 1999, pp. 1513-1517